Lumos Pharma Inc. (LUMO)
NASDAQ: LUMO
· Real-Time Price · USD
4.34
0.00 (0.00%)
At close: Dec 11, 2024, 10:00 PM
Lumos Pharma Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| Royalty Revenue | 2M | 1.5M | 220K |
| Royalty Revenue Growth | +33.33% | +581.82% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.21M | 3.68M | 3.78M | 4.16M | 3.89M | 4.15M | 4.36M | 4.49M | 3.92M | 3.68M | 3.62M | 3.43M | 3.38M | 4.56M | 3.96M | 4.63M | 5.16M | 4.15M | 3.33M | 4.38M | 8.28M | 5.64M | 5.57M | 5.43M | 7.59M | 7.91M | 8.29M | 6.69M | 7.91M | 8.9M | 8.23M | 7.18M | 7.75M | 9.13M | 9.16M | 7.68M | 7.38M | 7.26M | 8.37M |
| Selling, General, and Administrative Revenue Growth | +14.48% | -2.57% | -9.10% | +6.73% | -6.10% | -4.84% | -2.85% | +14.47% | +6.41% | +1.68% | +5.63% | +1.27% | -25.78% | +15.26% | -14.55% | -10.18% | +24.33% | +24.50% | -23.97% | -47.08% | +46.84% | +1.28% | +2.58% | -28.48% | -4.10% | -4.58% | +23.98% | -15.42% | -11.13% | +8.05% | +14.65% | -7.32% | -15.13% | -0.37% | +19.29% | +4.04% | +1.75% | -13.26% | n/a |
| Research and Development Revenue | 4.15M | 4.63M | 7.25M | 6.66M | 5.05M | 6.02M | 4.37M | 4.86M | 4.13M | 4.64M | 4.22M | 3.36M | 4.11M | 4.11M | 4.66M | 2.46M | 2.08M | 2.76M | 1.91M | 4.74M | 7.02M | 5.24M | 5.2M | 5.72M | 7.57M | 12.09M | 20.31M | 17.46M | 18.48M | 18.2M | 15.72M | 19.49M | 24.46M | 27.41M | 21.94M | 14.79M | 22.51M | 16.13M | 17.98M |
| Research and Development Revenue Growth | -10.28% | -36.13% | +8.88% | +31.93% | -16.24% | +37.88% | -10.14% | +17.75% | -11.11% | +10.05% | +25.59% | -18.26% | -0.02% | -11.74% | +89.20% | +18.70% | -24.90% | +45.04% | -59.82% | -32.50% | +34.12% | +0.65% | -9.05% | -24.43% | -37.38% | -40.49% | +16.34% | -5.51% | +1.54% | +15.74% | -19.32% | -20.33% | -10.75% | +24.95% | +48.27% | -34.27% | +39.54% | -10.29% | n/a |